Healthcare provider profile · identity verified

Manoj Pulicottil, M.D.

Internal Medicine · JACKSONVILLE, FL · NPI 1306877972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	573	172
Amlodipine Besylate	Amlodipine Besylate	430	121
Levothyroxine Sodium	Levothyroxine Sodium	380	107
Gabapentin	Gabapentin	318	80
Losartan Potassium	Losartan Potassium	304	89
Omeprazole	Omeprazole	276	82
Alprazolam	Alprazolam	272	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	201	30
Tamsulosin Hcl	Tamsulosin Hcl	201	60
Lisinopril	Lisinopril	197	55
Rosuvastatin Calcium	Rosuvastatin Calcium	194	62
Prednisone	Prednisone	185	100
Metformin Hcl	Metformin Hcl	184	56
Famotidine	Famotidine	182	57
Sertraline Hcl	Sertraline Hcl	176	51
Eliquis	Apixaban	170	27
Hydrochlorothiazide	Hydrochlorothiazide	167	52
Pantoprazole Sodium	Pantoprazole Sodium	136	46
Albuterol Sulfate Hfa	Albuterol Sulfate	135	34
Zolpidem Tartrate	Zolpidem Tartrate	133	18
Tramadol Hcl	Tramadol Hcl	129	26
Carvedilol	Carvedilol	128	38
Metoprolol Succinate	Metoprolol Succinate	126	36
Pravastatin Sodium	Pravastatin Sodium	123	38
Escitalopram Oxalate	Escitalopram Oxalate	122	35
Metoprolol Tartrate	Metoprolol Tartrate	122	37
Azithromycin	Azithromycin	118	73
Fluticasone Propionate	Fluticasone Propionate	118	45
Furosemide	Furosemide	118	38
Potassium Chloride	Potassium Chloride	117	38
Simvastatin	Simvastatin	114	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	109	17
Trazodone Hcl	Trazodone Hcl	96	28
Clopidogrel	Clopidogrel Bisulfate	94	24
Metformin Hcl Er	Metformin Hcl	93	28
Lorazepam	Lorazepam	90	23
Montelukast Sodium	Montelukast Sodium	88	23
Hydralazine Hcl	Hydralazine Hcl	86	24
Amoxicillin	Amoxicillin	82	44
Promethazine Hcl	Promethazine Hcl	75	11
Trulicity	Dulaglutide	73	14
Tresiba Flextouch U-100	Insulin Degludec	65	17
Temazepam	Temazepam	63	suppressed
Tizanidine Hcl	Tizanidine Hcl	62	16
Jardiance	Empagliflozin	58	15
Januvia	Sitagliptin Phosphate	57	11
Duloxetine Hcl	Duloxetine Hcl	56	15
Atenolol	Atenolol	55	16
Doxycycline Hyclate	Doxycycline Hyclate	54	40
Allopurinol	Allopurinol	53	17
Citalopram Hbr	Citalopram Hydrobromide	52	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	52	32
Ozempic	Semaglutide	52	14
Baclofen	Baclofen	48	12
Cephalexin	Cephalexin	48	35
Farxiga	Dapagliflozin Propanediol	48	12
Methocarbamol	Methocarbamol	48	24
Ibuprofen	Ibuprofen	47	17
Pregabalin	Pregabalin	47	11
Synthroid	Levothyroxine Sodium	47	12
Clonazepam	Clonazepam	45	suppressed
Valsartan	Valsartan	42	11
Ezetimibe	Ezetimibe	38	14
Meloxicam	Meloxicam	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Mirtazapine	Mirtazapine	37	13
Diclofenac Sodium	Diclofenac Sodium	36	16
Fluconazole	Fluconazole	36	15
Hydrocortisone	Hydrocortisone	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	23
Triamcinolone Acetonide	Triamcinolone Acetonide	36	23
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	11
Buspirone Hcl	Buspirone Hcl	34	13
Pioglitazone Hcl	Pioglitazone Hcl	34	11
Ketoconazole	Ketoconazole	33	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Mupirocin	Mupirocin	33	25
Mounjaro	Tirzepatide	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Spiriva Respimat	Tiotropium Bromide	32	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Ramipril	Ramipril	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Finasteride	Finasteride	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	17
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Linzess	Linaclotide	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Naproxen	Naproxen	20	suppressed
Procto-Med Hc	Hydrocortisone	20	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	11
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bydureon Bcise	Exenatide Microspheres	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Estradiol (Twice Weekly)	Estradiol	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	11
Warfarin Sodium	Warfarin Sodium	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lactulose	Lactulose	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Cevimeline Hcl	Cevimeline Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nystatin	Nystatin	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Glipizide	Glipizide	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Ambien Cr	Zolpidem Tartrate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diazepam	Diazepam	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error